Wildy Logo
(020) 7242 5778
enquiries@wildy.com

Book of the Month

Cover of Spencer Bower and Handley: Res Judicata

Spencer Bower and Handley: Res Judicata

Price: £449.99

Lord Denning: Life, Law and Legacy



  


Welcome to Wildys

Watch


NEW EDITION Pre-order The Law of Rights of Light 2nd ed



 Jonathan Karas


Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey [CRC] (eBook)


ISBN13: 9789403501369
Published: August 2022
Publisher: Kluwer Law International
Country of Publication: Netherlands
Format: eBook (ePub)
Price: £80.00
The amount of VAT charged may change depending on your location of use.


The sale of some eBooks are restricted to certain countries. To alert you to such restrictions, please select the country of the billing address of your credit or debit card you wish to use for payment.

Billing Country:


Sale prohibited in
Korea, [North] Democratic Peoples Republic Of

Due to publisher restrictions, international orders for ebooks may need to be confirmed by our staff during shop opening hours. Our trading hours are Monday to Friday, 8.30am to 5.00pm, London, UK time.


The device(s) you use to access the eBook content must be authorized with an Adobe ID before you download the product otherwise it will fail to register correctly.

For further information see https://www.wildy.com/ebook-formats


Once the order is confirmed an automated e-mail will be sent to you to allow you to download the eBook.

All eBooks are supplied firm sale and cannot be returned. If you believe there is a fault with your eBook then contact us on ebooks@wildy.com and we will help in resolving the issue. This does not affect your statutory rights.

This eBook is available in the following formats: ePub.

In stock.
Need help with ebook formats?




Also available as

Pharmaceutical Test Data Exclusivity is designed to provide expert guidance, chapter by chapter, on test data exclusivity rights for innovative pharmaceutical products in twenty-two major markets worldwide. Data exclusivity gives pharmaceutical companies a limited period of time in which clinical test data are exclusive to the innovator. Internationally, however, aside from prohibition against unfair commercial use, there are no specifics as to how these data are protected. This book will be the starting point for innovator pharmaceutical companies and their advisers to evaluate data exclusivity rules and opportunities around the world.

This book originated from a project conducted by the Pharma Committee of the International Association for the Protection of Intellectual Property (AIPPI). In addition to explaining the available regulatory data protection in each jurisdiction, contributors of chapters in this book, who are local experts, committee members and observers, provide detailed information and guidance on the degree to which test data exclusivity may be achieved in such areas of pharmaceutical research as the following:

  • infectious disease products
  • paediatrics products
  • chemical and biological products
  • agricultural products
  • animal health products
  • orphan drugs, and
  • new chemical entities

As an unmatched starting point for innovator pharmaceutical companies and their advisers to evaluate data exclusivity rules and opportunities around the world, this book will be an invaluable resource for IP professionals, governments, non-governmental organizations, and international organizations to promote and share IP laws and practices. By providing detailed information on the cutting-edge issues of IP and proposing an adequate balanced position to frame the issues, this book will be a valuable resource for pharmaceutical innovators on the various data exclusivity provisions available for innovative drug products in the listed countries.

Subjects:
Intellectual Property Law, eBooks
Contents:
List of Abbreviations
Foreword
Luiz Henrique do Amaral, President of AIPPI
Introduction
John C. Todaro, Martin Bensadon, Brigitte Carion-Taravella
Argentina
Martín Bensadon, Eugenio Hoss
Australia
Nicholas Tyacke, Eliza Saunders, Sarah McKenzie
Brazil
Ana Claudia Mamede Carneiro, Roberto Faria de Sant’Anna Junior
Canada
Charles Boulakia, Santosh Chari, Anita Nador
Chile
Ignacio Gillmore, José Santos Ossa, Camila Suarez Alcántara
China
Amy Feng, Alex Guan
Colombia
Ximena Castellanos
European Union
Mathilde Rauline, Muriel Morel-Pécheux, Maurane Cadinot, Nicolás Vincent Ruiz, Brigitte Carion-Taravella
India
Vidisha Garg
Israel
David Gilat
Japan
Takeshi S. Komatani, Takashi Fujita, Osamu Yamamoto, Yoshinori Shimizu, Masaru Nakajima
Republic of Korea
Yoon Suk Shin
Mexico
Carolina Ponce
Peru
Carlos Fernández-Dávila Winkler, Julisa Quiliche Chávez, Nicolle Pérez Mercado
Russia
Renat Krasnoperov
Kingdom of Saudi Arabia
Namir B. Sioufi
South Africa
Dirk Hanekom
Switzerland
Simon Holzer
Taiwan
Kevin C.W. Feng
Turkey
Ezgi Baklaci Gülkokar
United Arab Emirates
Namir B. Sioufi
United Kingdom
Daniel Lim
United States
Michael K. Stern